Skip to main content
Division of Hematology & Oncology Hematology Oncology

Coagulation Medicine Fellowship Program Curriculum

  • Pathophysiology and approach to diagnosis and treatment of congenital and acquired bleeding and clotting disorders.
  • Comprehensive care approach to hemophilia comprising, but not limited to: nursing, physical therapy, social work, home infusion, patient programs, national data collections, hemophilia treatment center networks.
  • Complex and comprehensive management of patients with hemophilia (+/- inhibitors), von Willebrand disease, and other rare bleeding disorders, including their management in the inpatient and outpatient settings.
  • Management of women with bleeding disorders. Participate in monthly combined Heme-Ob/Gyn clinic. Participate in the ongoing development of a new focus for “Women with Bleeding Disorders” (care, outreach).
  • Management of hereditary hemorrhagic telangiectasia (HHT). The UC San Diego Center for Bleeding and Clotting Disorders has been certified as a center of excellence for HHT  https://curehht.org/.
  • Management of patients with venous thromboembolism and cancer.
  • Diagnosis and management of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in collaboration with Pulmonary/Critical Care.
  • Differences and indications for anticoagulants, including direct oral anticoagulants (DOACs).
  • Hemostasis and coagulation assays and their appropriate diagnostic use with rotations through the special coagulation laboratory.
  • Incorporate point-of-care musculoskeletal ultrasound for rapid bleed detection, synovitis, and other common joint abnormalities into clinical decision-making and guided treatments.
  • Incorporate vascular point-of-care ultrasound imaging for the management of deep venous thromboembolism.
  • Acquire competence regarding the pathobiology of hemophilic arthropathy, and current options for interventions, indications, risks, and side effects for orthopedic procedures, synovial embolization, and (radio)synovectomies.
  • Participate in outreach activities involving patient advocacy groups, local Hemophilia Chapters, and national and international organizations such as the National Hemophilia Foundation and the World Federation of Hemophilia, Hemophilia Camp.
  • Participate in ‘transition of care’ from pediatric centers to adult treatment centers
  • Exposure to self-infusion training and teaching venues for patients with hemophilia and bleeding disorders.
  • Opportunities for global involvement to advocate for diagnosis and treatment of bleeding disorders in the developing world, especially at the HTTC’ WFH Twinning site in Maputo, Mozambique.
  • Exposure to the clinical trial program encompassing gene therapy and novel clotting factor preparations.

Educational Resources

  • Epidemiology/CREST 
  • Point-of-care (POC) musculoskeletal ultrasound (MSKUS) program, comprising virtual and hands-on training classes (CME-accredited), with the opportunity to directly apply the new knowledge during clinics and rotations in the hemophilia clinic. (funding provided)
  • Center for Bleeding and Clotting Disorders at UCSD is an international leader in the field with several state-of-the-art ultrasound equipment. In addition, interested fellows will be outfitted with hand-held probes that they can use at all times. Annette von Drygalski (APD) is certified in MSKUS by the Alliance for Physician Certification & Advancement (APCA).
  • Point-of-care ultrasound (POCUS) for vascular imaging, particularly deep venous thromboembolism (DVT). - A CME-curriculum class is in development. Participants will be enabled to work towards APCA certification after completion of this program. As with the MSKUS program fellows will be outfitted with a hand-held probes that they can use at all times.
  • Pre-ASH and pre-HTRS workshops.
  • Hemophilia Academy (applications will be supported)
  • Participation in weekly Friday ACGME-curriculum conference from 8-9 am as pertinent to Hemostasis/Thrombosis and non-malignant Hematology.
  • Participation in weekly Fellow case conferences from 9-10 am if Heme cases are discussed.
  • Participation in the weekly ACGME Hematology/Oncology Fellowship curriculum conference if Heme cases are discussed.
  • Participation in the weekly ACGME Hematology (HFFTP) Fellowship curriculum conference if Heme cases are discussed.